MLchartDataset catalogue

Campath

Term · Oncology and biomedicine · MLC-T-ONC-001354

A drug used to treat B-cell chronic lymphocytic leukemia. It is also being studied in the treatment of other types of cancer. Campath binds to a protein called CD52, which is found on some types of immune cells and cancer cells. This may help the immune system kill cancer cells. Campath is a type of monoclonal antibody. Also called alemtuzumab.

Table 1. Record
IdentifierMLC-T-ONC-001354
FieldOncology and biomedicine
Synonymsalemtuzumab
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-001354",
  "term": "Campath",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat B-cell chronic lymphocytic leukemia. It is also being studied in the treatment of other types of cancer. Campath binds to a protein called CD52, which is found on some types of immune cells and cancer cells. This may help the immune system kill cancer cells. Campath is a type of monoclonal antibody. Also called alemtuzumab.",
  "synonyms": [
    "alemtuzumab"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/campath/"
}

Record 4,053 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.